You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
AAW WARFIGHTING CAPABILITIES EVALUATION MODEL
SBC: MITECH, INC. Topic: N/ATHE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A HIGH LEVEL COMPUTERIZED EVALUATION MODEL THAT WILL PREDICT THE WARFIGHTING CAPABILITIES OF A GIVEN DEFINED ARCHITECTURE AGAINST A GIVEN THREAT WITH RESPECT TO ANTI-AIR WARFARE (AAW). THE AAW FORCE LEVEL ATTRIBUTES/DRIVERS AS DEFINED BY SPAWAR 314, AAW DIVISION OF WARFARE SYSTEMS ARCHITECTURE AND ENGINEERING DIRECTORATE, WILL BE ADDRESSED IN TERMS OF TH ...
SBIR Phase I 1989 Department of DefenseNavy -
A BIOLOGICAL APPROACH TO THE SYNTHESIS OF META-HYDROXY PHENYLACETYLENE FROM PHENYLACETYLENE
SBC: Bio-technical Resources, L.p. Topic: N/AACETYLENE-TERMINATED RESINS ARE ONE OF SEVERAL CANDIDATE POLYMERIC MATERIALS BEING DEVELOPED FOR POTENTIAL AEROSPACE APPLICATIONS. THE ACETYLENE-TERMINATED RESINS POSSESS PROPERTIES REQUIRED FOR THE PROPOSED APPLICATIONS SUCH AS TEMPERATURE, MOISTURE, AND SHEAR INSENSITIVITY. THE LIMITING FACTOR FOR THE COMMERCIAL MANUFACTURE OF THESE RESINS IN A COST-EFFECTIVE METHOD FOR THE SYNTHESIS OF AN ESSEN ...
SBIR Phase I 1987 Department of DefenseAir Force -
Accelerated Minimally Invasive Brain Clot Evacuation Using Guided Drug Delivery
SBC: InseRT Topic: 105SignificanceWe propose to extend and customize inseRT MRI s Real Time MR image guided surgical platformoriginally developed for cerebral biopsy and direct injection cancer therapiesto overcome shortcomings in CT guidance of a promising new thrombolytic therapy for intracerebral hemorrhageICHICH is a devastating injury creating stroke like outcomes inpeople in the USA each yearDamage from mechanica ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Accelerating Functional Maturation of Human Neurons for High-Throughput Screening
SBC: BrainXell, Inc Topic: 44Project Summary/AbstractNeurological and psychiatric disorders, including drug abuse and addiction, exert a devastating personal and economic toll on patients, families, caregivers, and society. This is in part due to our failure in developing effective medications, which in turn is due to the use of drug discovery platforms that are often not relevant to target diseases. The recent development of ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
ACCESSORY APARTMENTS-DEVELOPING A PRIVATE PARTNERSHIP TO MARKET THE CONCEPT AND COUNSEL THE HOMEOWNER
SBC: Patrick H Hare Planning & Des Topic: N/AACCESSORY APARTMENTS BENEFIT OLDER HOMEOWNERS. THEY CAN PROVIDE INCOME, SECURITY, COMPANIONSHIP, AND A SOURCE OF SERVICES IN RETURN FOR RENT REDUCTIONS. THEY ALSO CREATE INEXPENSIVE RENTAL HOUSING, AND, BECAUSE OF THE BENEFITS LISTED ABOVE, A MEANS TO HELP OLDER HOMEOWNERS AGE IN PLACE.IN CONTRAST, INSTALLATION OF ACCESSORY APARTMENTS IS RARELY SEEN AS A WAY FOR BUSINESS PEOPLE TO MAKE MONEY. AS A ...
SBIR Phase II 1987 Department of Health and Human Services -
Adaptive Interference Rejection Algorithms
SBC: Applied Research In Acoustics LLC Topic: N182116To address the need to mitigate cooperative and noncooperative in-band interference in airborne anti-submarine warfare (ASW) systems, ARiA will develop and demonstrate the feasibility of signal and information processing algorithms for mitigating various types of in-band interference. ARiA will develop and evaluate (1) model-based adaptive signal processing in space, time, and Doppler to mitigate ...
SBIR Phase I 2019 Department of DefenseNavy -
Addditive-manufactured Low-Cost Upper-stage Propellant (ALCUP) Tank
SBC: Exo-Atmospheric Technologies LLC Topic: MDA18021An Additive-manufactured, Low-Cost, Upper-stage Propellant (ALCUP) tank architecture is proposed that integrates different AM techniques to produce a scalable, modular tank architecture which allows for incorporation of different tank features required to retain mission flexibility, while utilizing advanced concepts to decrease inert fraction. The innovative design and manufacturing technique util ...
SBIR Phase I 2019 Department of DefenseMissile Defense Agency -
Additive Manufacturing of Large, Complex 3D, Metal and Alloy Structures for High-Vacuum Applications
SBC: XANTHO TECHNOLOGIES LLC Topic: 24aWe propose to develop the know-how necessary to utilize additive manufacturing (AM) to fabricate hardware having the material and structural characteristics needed to meet exacting high-vacuum requirements of scientific R&D. Additive manufacturing (AM) offers the potential to realize the production of monolithic components while significantly reducing investments of resources including time, effor ...
SBIR Phase I 2019 Department of Energy -
A DRUG ABUSE PREVENTION PROGRAM FOR INDUSTRY
SBC: ISA ASSOCIATES INC Topic: N/ATHE PURPOSE OF THIS PROJECT IS TO DEVELOP AND TEST A HEALTH-PROMOTION-ORIENTED DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM FOR INDUSTRY. THE PROGRAM WILL USE DRUG AND ALCOLHOLABUSE PREVENTION STRATEGIES APPROPRIATE FOR WORKING ADULTS, CAST IN A HEALTH PROMOTION FRAMEWORK. PHASE I ACTIVITIES INCLUDE: (1) DEVELOPING A MODEL OF HEALTH PROMOTION/HEALTH BEHAVIOR RESEARCH LITERATURE, THE INTERVIEWS WITH H ...
SBIR Phase II 1989 Department of Health and Human Services -
A Dual Molecular/Targeting Therapy for PanCa
SBC: SYNERGENE THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic Cancer (PanCa). Over 90% of these will die of the disease making PanCa one of the most devastating human malignancies. The current 5-year survival rate of less than 4% has changed little in the last 20 years despite improvements in therapy including the introduction of chem ...
STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health